Benzodiazepine Detox UAE: The Three-Month Permit Rule

In brief: For residents of Dubai, Abu Dhabi and the wider Emirates, the hardest part of coming off a benzodiazepine is not the taper. It is that the medication itself sits inside a controlled-substance regime most people only discover when they try to travel with it. I built the program on this page after living the alternative, and I will tell you exactly what the three-month permit rule means for you, why a private outpatient taper is structurally difficult inside the Emirates, what we actually do across four to twelve weeks, what the research says about each therapy we use, and where the evidence stops. It is not a promise of a cure.

Benzodiazepine detox for UAE residents runs into a set of rules that exist nowhere else in quite this form: a federal narcotics law, three separate health regulators, an import permit measured in months, and an outpatient prescribing position that quietly rules out the way most of the world tapers.

Read this part first. Do not reduce or stop a prescribed benzodiazepine on your own, and never stop one abruptly. Abrupt cessation can cause seizures and can be life-threatening. Any change to your dose belongs with a physician who knows your history. If you are in crisis, the Suicide and Crisis Lifeline number used internationally by many callers is 988 in the United States; within the UAE, the Ministry of Health operates a national mental health support line.

Why I Built a Program for This

I did not come to this work with a plan. I came to it as a patient who had run out of options — years of programs, prescriptions and discharges that managed me and never restored me — and I left with a question I have been answering ever since: why does the system built to help people so reliably return them worse than it found them?

In the Emirates that question takes a form I have not seen anywhere else. The federal narcotics law, the three regulators, the import permit and the outpatient prescribing position are all designed to control the drug, and they do it well. None of them is designed to get a person off it. A resident who wants to stop is left holding a medication the state watches closely, with a reduction pathway the same state has quietly made impractical. The people who call us from Dubai and Abu Dhabi have usually worked that out for themselves. They are not asking whether the system cares. They are asking what actually happens next.

Holistic Sanctuary has been open since 2011, and more than 1,000 clients have come through in that time. I am precise about what that figure is: a count, not a claim. It proves nothing about any individual and I will never present it as proof of a cure. What it represents is fifteen years of doing this one person at a time and being present for almost every hour of it — which is the only reason I can describe what an Emirati guest’s taper here involves without guessing.

Four Things That Make the Emirates Different

Benzodiazepine dependence is the same condition in Dubai as it is in London. What is not the same is the system around it, and four features of that system shape every decision a UAE resident makes.

One federal narcotics law. Federal Decree-Law No. 30 of 2021 on Combating Narcotics and Psychotropic Substances governs controlled medicines across all seven emirates, and benzodiazepines sit inside its classification framework rather than outside it.

Three health regulators, not one. Dubai is regulated by the Dubai Health Authority, Abu Dhabi by its own Department of Health, and the northern emirates directly by the Ministry of Health and Prevention. Which rules apply to your prescription depends on where you live, and the three do not move in step.

An import permit measured in months. Bringing a controlled medicine into the country for personal use requires a permit and is capped at a defined supply period — a constraint most residents never encounter until the first time they travel with their own prescription.

A restriction on private outpatient prescribing. This is the one that matters clinically, and it is the least discussed. It is the reason the standard international approach to a benzodiazepine taper is difficult to run privately inside the Emirates, and it is covered in detail below.

Taken together they do not make treatment impossible. They make one particular route — the slow private outpatient taper that most of the world defaults to — considerably harder to arrange than it would be elsewhere.

Why a Private Outpatient Taper Is Difficult in the Emirates

This is the part almost nobody explains, and it is the reason so many Gulf residents end up stuck.

The UAE government’s own guidance states that narcotic, psychotropic and other controlled drugs of Class A or B are neither freely available in the UAE nor freely importable. Class A psychotropics must be prescribed on the official psychotropic prescription form. In Abu Dhabi, narcotics for in-patients must be written on the approved narcotic prescription form — and out-patient narcotic prescriptions from the private sector are, in the government’s own wording, not usually allowed. There are federal restrictions on the duration of prescription supply for controlled drugs in both classes.²

The whole framework sits under Federal Decree-Law No. 30 of 2021 on Combating Narcotics and Psychotropic Substances.³

Read those restrictions together and the practical consequence is stark. The standard international approach to benzodiazepine dependence — a long, slowly adjusted outpatient taper managed by a private physician who can rewrite the script every few weeks as the dose comes down — is structurally difficult to run inside the Emirates. Supply duration is limited. Prescription forms are controlled. Private-sector outpatient narcotic prescribing is restricted.

None of that is a criticism of the system. It exists for reasons, and the reasons are not unreasonable. But it means a resident here is not choosing between a home taper and a residential one on equal terms. For many people the home option is constrained before the clinical conversation even begins.

Dubai, Abu Dhabi and the Northern Emirates

The Emirates are one country with more than one health authority, and which one governs your care depends on where you live.

For Dubai residents

Care in the emirate is regulated by the Dubai Health Authority, which licenses the private hospitals and clinics most expatriate and Emirati professionals actually use. Dubai has the densest private healthcare market in the region, which means a resident here has the widest choice of psychiatrists and the same federal ceiling on controlled prescribing as everyone else. The gap is not access to a doctor. It is access to a long, flexible, privately managed taper.

For Abu Dhabi residents

The emirate is regulated by its own Department of Health, and it is Abu Dhabi’s rules that the federal guidance singles out on narcotic prescription forms and private outpatient prescribing.² Abu Dhabi is also home to the country’s principal government treatment institution for substance dependence. For a resident who wants a private, discreet, non-institutional route, the options narrow quickly.

For Sharjah and the northern Emirates

Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah are regulated directly by the Ministry of Health and Prevention rather than an emirate-level authority. Residents there typically travel to Dubai or Abu Dhabi for specialist psychiatric care already, so the journey has simply started earlier.

For expatriate residents on employer insurance

Mandatory health insurance in Dubai and Abu Dhabi is built around employer-provided plans. That creates a specific and rarely discussed problem: a claim for treatment of substance dependence is a claim processed through an employer’s scheme. Whatever the confidentiality assurances, a great many professionals decide the risk is not worth it and pay privately instead. That decision is usually made before any clinician is consulted. In practice this shapes the whole inquiry: by the time someone in Dubai or Abu Dhabi contacts a facility abroad, they have usually already decided that privacy is non-negotiable and that the arrangement will be self-funded. Saying so plainly at the outset saves a conversation neither side wants to have later.

Getting From the Emirates to Tulum

There is no non-stop service between the Emirates and Cancún. Routings connect through Europe — London, Paris, Amsterdam, Madrid — or through a North American hub, and the realistic expectation is a full travel day, often closer to twenty hours door to door. From Cancún the transfer to the sanctuary is by private car.

Two practical consequences follow, and both are clinical rather than promotional.

First, the medication you travel with has to be correctly documented at both ends: the UAE permit and prescription for the outbound leg and for your return, and whatever the destination requires on arrival. That is a question to put to the Mexican consulate before booking, not after.

Second, arrival day is not the day to make the first dose reduction. After twenty hours in transit across an eleven-hour time difference, sleep is already disrupted, which is the exact variable a taper is most sensitive to. The first days here are assessment: physician-led intake, bloodwork, cardiac screening, and rest.

What Is Not Available Locally

We will not tell you that nothing comparable exists anywhere in the world, because we cannot verify that and neither can anybody else making the claim. What we can describe precisely is the configuration, and the configuration is what a Gulf resident is actually traveling for.

One guest at a time rather than a group program. A four-to-twelve-week duration rather than the twenty-eight days that most insurance-shaped programs were built around. A physician-led taper prescribed and dispensed on site, so the prescribing constraint that limits an outpatient taper at home does not apply. Screening before anything begins: blood pressure, bloodwork, EKG, stress test and echocardiogram, with twenty-four-hour nursing throughout.

Alongside the taper, the elements that make it survivable rather than merely supervised — sleep support, nutrition, structured daily activity, breathwork and bodywork, one-to-one psychological work, and where a physician judges it appropriate, intravenous nutrient support. An oceanfront setting rather than a clinical ward, which matters more than it sounds like it should when someone is not sleeping.

That combination, at that ratio, for that duration, under that oversight, in that setting, is the specific thing on offer. It is a description, not a superlative.

What We Actually Do Here

The taper is inpatient and medically supervised from the first day to the last, with nursing cover running 24 hours a day across a morning shift, an evening shift and two to three night shifts, with at least four nurses on duty across a 24-hour period.

Dr. Jose A. Jimenez, MD, our Medical Director, reviews and clears each client before treatment begins and signs off on the medical picture the taper is built on. I am not a physician and I do not pretend to be one; he is, and every clinical decision on this page runs through him.

It begins with a full workup: bloodwork, EKG, cardiac evaluation, and an honest accounting of everything currently in the system, including alcohol, opioids and other prescriptions. Polypharmacy is the norm rather than the exception among the people who come to us, and it changes the plan.

From there the reduction is stepwise and continuously monitored, slowed whenever the clinical picture calls for it. The schedule is set and adjusted clinically, based on the person in front of us rather than a printed timetable. Sleep, nutrition, hydration and autonomic symptoms are managed around the clock rather than left to the guest to endure between appointments.

What we do not do is substitute. Nobody leaves here on a maintenance prescription for something else, and nobody is moved sideways onto a longer-acting drug they will have to come off in a year’s time somewhere else. I have watched that pattern for fifteen years — a person “successfully” off one benzodiazepine and quietly on another — and I refuse to run it here.

Medication-free is the destination. If that is not what someone wants, we are the wrong facility, and we say so during the inquiry.

The taper also happens here, in-house. It is not outsourced to a detox unit elsewhere and then handed back to us afterwards.

Why Twelve Weeks, Not Less

I hear the objection before it’s finished: twelve weeks is a long time to be away from a life. I understand that completely. What I have also seen, in this field for fifteen years, is what happens when a timeline is compressed to fit a calendar instead of a body.

The standard outpatient answer to a benzodiazepine dependence is a taper measured in many months, sometimes years. That advice exists for good reason, and I am not going to tell you it is wrong. The difficulty is what it looks like for the person living it: a very long stretch of time spent partly symptomatic, alone, still working, still parenting, still driving, and repeatedly deciding whether today is the day to hold the reduction or go back up.

Carrying out a reduction inside a facility, with 24-hour nursing cover, continuous monitoring and full-time support, changes what a person is able to tolerate — and therefore changes what is achievable in a given stretch of time.

Programs here run four to twelve weeks, and longer when a taper needs it. We do not run a five-to-seven-day detox, because a week is long enough to get someone through the sharpest edge of withdrawal and send them home fragile, which is how people end up back on the prescription within the month.

Twelve weeks is the floor, not a target we hit early when things go well. Some tapers here run slower than expected because the clinical picture demands it, and we would rather extend a stay than hit a date. It also does not mean this is easy. It means it is supervised, and that the hardest part happens somewhere with a physician on site rather than in a bedroom at four in the morning.

Innovation, and Where the Evidence Stops

Johnny Tabaie has spent two decades on this work, more than fifteen of them running the facility, and more than 1,000 clients have come through since 2011, taking part in more than 5,000 ceremonies. Those are the numbers, and we publish them conservatively on purpose.

Here is the part that most facilities leave out, and the reason we put it on the page instead.

Holistic Sanctuary takes no government, institutional, nonprofit or corporate funding. The protocol has not been licensed out and is not opened to outside researchers, because the founder’s assessment is that an independent protocol handed to a pharmaceutical partner comes back synthesised and patented. That is a deliberate commercial decision with a real cost attached to it: there is no third-party trial data on this protocol, and we are not going to imply that there is.

What the wider literature does say is worth knowing before you choose anywhere. A Cochrane review of 38 randomized trials covering 2,543 people found it was not possible to draw firm conclusions about any medication for benzodiazepine discontinuation, with certainty rated low or very low throughout.⁴ A companion Cochrane review of 25 trials covering 1,666 people found that cognitive behavioral therapy plus a taper helped at three months — risk ratio 1.51 — and that the benefit did not persist past six.⁵

So when a program anywhere in the world tells you it has the answer to benzodiazepine dependence, the honest response is that the field does not yet have one. What it has is a supervised taper, psychological support alongside it, and a great deal of uncertainty about the year that follows. Innovation in this category means being candid about that and building around it — not claiming to have solved it.

What Each Therapy Does — and What the Research Actually Shows

I built this section because I’m tired of watching this industry either oversell every therapy as a miracle or say nothing real about any of them. Below is what the published research says about each modality that runs alongside a benzodiazepine taper here — general findings from clinical and scientific literature, not claims about outcomes at this facility or for any individual guest. Where the evidence is strong, I say so. Where it’s early or mixed, I say that too.

One thing first. The reduction schedule is the spine of the program. Everything below exists to make that schedule survivable. None of it replaces it, and no component of this program has been tested in a randomized controlled trial as a treatment for benzodiazepine dependency. I am not going to imply otherwise.

The Brain Repair IV Protocol

The Brain Repair IV Drip is a proprietary formulation I developed myself, incorporating amino acids, peptides and a nature-derived alkaloid. It is the intravenous component of the Pouyan Method built for benzodiazepine and SSRI recovery, sequenced and dosed to the individual under nursing supervision. It is one component of a comprehensive, individualized protocol, intended to support the body and brain during the recovery process rather than presented as a guaranteed cure or a replacement for individualized medical care. The formulation, administration sequence and available evidence are documented separately on our Brain Repair IV Protocol page.

NAD+ Support and Amino Acids

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell in the body requires for energy metabolism, and levels are known to decline with age and with chronic substance use. NAD+ and amino acid support are used here to assist the body’s own restorative processes during a period of significant physical demand. This is an area where clinical research is still developing, and we do not claim it treats any specific condition. I will also say directly what I make every member of staff say: NAD is a supportive therapy here. It is not the Brain Repair Protocol, and I do not allow it to be described as if it were.

Hyperbaric Oxygen Therapy (HBOT)

HBOT increases the amount of oxygen dissolved in blood plasma by having a person breathe oxygen at elevated atmospheric pressure. A 2024 review in Frontiers in Neurology describes how this process can promote mitochondrial function, new blood vessel growth, and reduced inflammatory signaling (lower TNF-α and IL-6) in nervous system tissue. HBOT is FDA-cleared for a specific list of conditions — wound healing, decompression sickness and carbon monoxide poisoning among them — and the Undersea and Hyperbaric Medical Society’s approved indications do not include benzodiazepine dependency. Its use for neurological and psychiatric conditions remains an active area of research rather than an approved indication. At Holistic Sanctuary, it is offered as a supportive therapy within a broader protocol, not as a treatment for any diagnosis on its own.

Red Light Therapy and Infrared Sauna

Red and near-infrared light in the 600–1,100 nanometer range is absorbed by an enzyme called cytochrome c oxidase inside mitochondria, increasing cellular ATP production — a mechanism reviewed extensively by Harvard-affiliated researcher Michael Hamblin. This is the basis for red light therapy’s documented effects on collagen production, wound healing and inflammation at the cellular level. Infrared sauna use operates differently, through heat: a study published in JAMA Internal Medicine associated frequent sauna use with reduced cardiovascular risk, and infrared heat exposure has been shown to activate heat shock proteins involved in cellular repair and to promote sweat-based excretion of certain heavy metals and organic compounds. Both are offered here as restorative, supportive therapies — not as treatments for any specific disease.

Therapeutic Massage

A widely cited review by Tiffany Field and colleagues, published in the International Journal of Neuroscience, found that massage therapy was associated with an average 31% decrease in cortisol and increases of 28% in serotonin and 31% in dopamine across a range of populations and conditions, including stress, pain and mood-related studies. In a benzodiazepine taper, where the nervous system is being asked to do without a brake it has leaned on for years, that matters. Massage is included as bodywork that supports the nervous system during an intensive period of change — not as a treatment for any underlying condition.

Yoga, Breathwork and Meditation

A systematic review in Health Psychology Review examined the mechanisms by which yoga reduces stress and found consistent evidence for effects on cortisol, inflammatory markers (IL-6, C-reactive protein) and psychological measures including self-compassion and positive affect. A separate controlled study of medical students found a statistically significant reduction in perceived stress after six weeks of yoga and meditation practice. These practices are part of daily life here because the evidence for their effect on stress physiology is genuinely strong — not because we present them as a cure for anything.

Detox Baths, Juice Cleanses, Superfoods and Organic Nutrition

The nutritional program is built around what your body specifically needs to rebuild during a taper — not a generic cleanse. Real, whole-food, organic nutrition supporting liver function and cellular repair is foundational to every other therapy in this program; a depleted body cannot make full use of any of the modalities above it. Detox baths, juice cleanses and superfood nutrition sit in the same category: supportive, restorative, and honestly described as such.

How These Are Scheduled

Nothing here runs on a fixed weekly timetable that every guest moves through together. Sessions are placed around where a person is in their reduction — heavier support in the days after a step down, lighter when a dose is holding steady — and the physician can pause any of it. If a therapy is not appropriate for someone on the day, it does not happen on the day, and nothing about the reduction schedule changes because of it. The taper is the fixed point; everything else moves around it.

What Brought Me to This Work

I am not a physician, and I have never presented myself as one. I don’t diagnose and I don’t prescribe. What I do is design the protocol, lead the healing side of this work, and stay personally involved in every case at this facility. In fifteen years of operation there has been no guest death at this facility. I state that once, plainly, because it’s true and because it is the direct result of the screening and staffing decisions on this page — never as a guarantee about your own outcome, which no honest program can offer anyone.

What We Do Not Claim

We do not claim a cure and we publish no success rate. We do not claim that any modality we offer eliminates withdrawal or replaces a taper.

What runs alongside a taper here is the Brain Repair Protocol — an intravenous formulation of amino acids, peptides and neurotransmitter compounds, given not as a single treatment but as a sequence: once, twice or three times over a set number of days, across one to four weeks, dosed to the individual and administered under nursing supervision. Johnny Tabaie developed it over two decades and it is the component of the Pouyan Method built for benzodiazepine and SSRI recovery. The formulation itself is proprietary and unpublished, and the reason is stated plainly elsewhere on this site: the facility is independently funded, runs no externally sponsored trials, and does not license the protocol out. It supports what chronic benzodiazepine exposure depletes. It does not replace the taper, and we do not claim it removes withdrawal.

We also do not claim that a residential taper abroad is right for everyone. Admission is by medical clearance, and there are medical pictures for which the correct answer is a hospital closer to home.

Read Next

• Benzodiazepine detox and rehab — the residential program and the supervised taper itself.
• Benzodiazepine withdrawal — the timeline by half-life and the three rules of a safe taper.
• Benzodiazepine treatment — what 63 controlled trials show, and the five questions to ask any program.
• Benzodiazepine detox for Swiss residents — the same problem under a thirty-day export limit.

Frequently Asked Questions

Can UAE residents travel with a prescribed benzodiazepine?

Yes, with documentation. The Ministry of Health and Prevention permit covers import for personal use up to a quantity not exceeding the patient’s need for a maximum of three months, supported by a prescription issued within the last three months carrying the dose, dosage form, treatment duration and the physician’s details with a facility stamp. The destination country has its own separate requirements.

Why is a benzodiazepine taper hard to arrange privately in Dubai or Abu Dhabi?

Because controlled prescribing is restricted. UAE government guidance states that Class A and B controlled medicines are not freely available, that Class A psychotropics require the official prescription form, and that in Abu Dhabi out-patient narcotic prescriptions from the private sector are not usually allowed, with federal limits on supply duration.

Is treatment abroad confidential for a Gulf professional?

Admission here is private and self-funded, with no insurer and no employer scheme in the chain, and guests are seen one at a time. What nobody can honestly offer is invisibility: carrying controlled medication across a border generates documentation in both directions.

How long is the journey from Dubai or Abu Dhabi?

There is no non-stop service to Cancún. Routings connect through Europe or North America and typically run close to twenty hours door to door, followed by a private transfer.

Is there proof this protocol works?

There is no third-party trial data on this protocol, and we say so directly. The facility takes no institutional or corporate funding and has not licensed the protocol out. Across the wider field, a Cochrane review of 38 medication trials could not draw firm conclusions for any drug, and the strongest psychological finding faded after six months.